K152571 is an FDA 510(k) clearance for the Stivax. Classified as Stimulator, Electro-acupuncture (product code BWK).
Submitted by Biegler GmbH (Mauerbach, AT). The FDA issued a Cleared decision on May 26, 2016 after a review of 260 days - an extended review cycle.
This device falls under the Neurology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.
View all Biegler GmbH devices